Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2007

Open Access 01-12-2007 | Original investigation

Exacerbation of acidosis during ischemia and reperfusion arrhythmia in hearts from type 2 Diabetic Otsuka Long-Evans Tokushima Fatty rats

Authors: Ryuko Anzawa, Shingo Seki, Kazuaki Horikoshi, Masayuki Taniguchi, Seibu Mochizuki

Published in: Cardiovascular Diabetology | Issue 1/2007

Login to get access

Abstract

Background

Sensitivity to ischemia and its underlying mechanisms in type 2 diabetic hearts are still largely unknown. Especially, correlation between reperfusion induced ventricular arrhythmia and changes in intracellular pH has not been elucidated.

Methods and results

Male Otsuka Long-Evans Tokushima Fatty (OLETF) rats at 16 and 32 weeks of age were used along with age-matched nondiabetic Long-Evans Tokushima Otsuka (LETO) rats. Hearts from rats in these 4 groups were perfused in the working heart mode, thus inducing whole heart ischemia. At 16 weeks of age, no differences in blood glucose levels or incidence and duration of reperfusion arrhythmia were found between the strains. At 32 weeks of age, both impaired glucose tolerance and obesity were observed in the OLETF rats. Further, the duration of reperfusion-induced ventricular fibrillation (VF) was significantly longer in the OLETF rats, while the pH level was significantly lower and proton contents were significantly higher in coronary effluent during ischemia in those rats. Following treatment with troglitazone, improvements in pH and proton level in coronary effluent during ischemia were observed, as was the duration of reperfusion-induced VF in OLETF rats at 32 weeks of age.

Conclusion

The hearts of spontaneously diabetic OLETF rats were found to be more susceptible to ischemic insult. Troglitazone treatment improved ischemic tolerance by improving glucose metabolism in the myocardium of those rats.
Appendix
Available only for authorised users
Literature
1.
go back to reference Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso MM: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339: 229-234. 10.1056/NEJM199807233390404.CrossRefPubMed Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso MM: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339: 229-234. 10.1056/NEJM199807233390404.CrossRefPubMed
2.
go back to reference Devereux RB, Roma MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Howard BV: Impact of diabetes on cardiac structure and function. The Strong Heart Study. Circulation. 2000, 101: 2271-2276.CrossRefPubMed Devereux RB, Roma MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Howard BV: Impact of diabetes on cardiac structure and function. The Strong Heart Study. Circulation. 2000, 101: 2271-2276.CrossRefPubMed
3.
go back to reference Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N, Ohmori K, Matsuo H: Alteration in left ventricular diastolic fillingand accumulation of myocardial collagen at insulin-resistantprediabetic stage of a type II diabetic rat model. Circulation. 2000, 101: 899-907.CrossRefPubMed Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N, Ohmori K, Matsuo H: Alteration in left ventricular diastolic fillingand accumulation of myocardial collagen at insulin-resistantprediabetic stage of a type II diabetic rat model. Circulation. 2000, 101: 899-907.CrossRefPubMed
4.
go back to reference Chen H, Higashino H, Kamenov ZA, Azuma M, Lee WH, Yang XQ, Zhou DJ, Yuan WJ: Preserved post ischemic heart function in sucrose-fed type 2 diabetic OLETF rats. Life Sciences. 2003, 72: 2839-2851. 10.1016/S0024-3205(03)00189-9.CrossRefPubMed Chen H, Higashino H, Kamenov ZA, Azuma M, Lee WH, Yang XQ, Zhou DJ, Yuan WJ: Preserved post ischemic heart function in sucrose-fed type 2 diabetic OLETF rats. Life Sciences. 2003, 72: 2839-2851. 10.1016/S0024-3205(03)00189-9.CrossRefPubMed
5.
go back to reference Maddaford TG, Russell JC, Pierce GN: Postischemic cardiac performance in the insulin-resistant JCR: LA-cp rat. Am J Physiol. 1997, 273: H1187-H1192.PubMed Maddaford TG, Russell JC, Pierce GN: Postischemic cardiac performance in the insulin-resistant JCR: LA-cp rat. Am J Physiol. 1997, 273: H1187-H1192.PubMed
6.
go back to reference Sidell RJ, Cole MA, Draper NJ, Desrois M, Buckingham RE, Clarke K: Thiazolidinedione treatment normalizes insulin resistance andischemic injury in the Zucker Fatty rat heart. Diabetes. 2002, 51: 1110-1117. 10.2337/diabetes.51.4.1110.CrossRefPubMed Sidell RJ, Cole MA, Draper NJ, Desrois M, Buckingham RE, Clarke K: Thiazolidinedione treatment normalizes insulin resistance andischemic injury in the Zucker Fatty rat heart. Diabetes. 2002, 51: 1110-1117. 10.2337/diabetes.51.4.1110.CrossRefPubMed
7.
go back to reference Anzawa R, Bernard M, Tamareille S, Baetz D, Confort-Gouny S, Gascard JP, Cozzone P, Feuvray D: Intracellular sodium increase and susceptibility to ischaemia in hearts from type 2 diabetic db/db mice. Diabetologia. 2006, 49: 598-606. 10.1007/s00125-005-0091-5.CrossRefPubMed Anzawa R, Bernard M, Tamareille S, Baetz D, Confort-Gouny S, Gascard JP, Cozzone P, Feuvray D: Intracellular sodium increase and susceptibility to ischaemia in hearts from type 2 diabetic db/db mice. Diabetologia. 2006, 49: 598-606. 10.1007/s00125-005-0091-5.CrossRefPubMed
8.
go back to reference Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T: Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 1992, 41: 1422-1428. 10.2337/diabetes.41.11.1422.CrossRefPubMed Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T: Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 1992, 41: 1422-1428. 10.2337/diabetes.41.11.1422.CrossRefPubMed
9.
go back to reference Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olfsky J: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Eng J Med. 1994, 331: 1188-1193. 10.1056/NEJM199411033311803.CrossRef Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olfsky J: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Eng J Med. 1994, 331: 1188-1193. 10.1056/NEJM199411033311803.CrossRef
10.
go back to reference Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DWG, Higgins AJ, Julian DG, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA, Riva E, Russell DC, Sheridan DJ, Winslow E, Woodward B: The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion. Cardiovasc Res. 1988, 22: 447-455.CrossRefPubMed Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DWG, Higgins AJ, Julian DG, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA, Riva E, Russell DC, Sheridan DJ, Winslow E, Woodward B: The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion. Cardiovasc Res. 1988, 22: 447-455.CrossRefPubMed
11.
go back to reference Yagi K, Kim S, Wanibuchi H, Yamashita T, Yamamura Y, Iwao H: Characteristics of diabetes, blood pressure and cardiac and renal complications in Otsuka Long Evans Tokushima Fatty rats. Hypertension. 1997, 29: 728-735.CrossRefPubMed Yagi K, Kim S, Wanibuchi H, Yamashita T, Yamamura Y, Iwao H: Characteristics of diabetes, blood pressure and cardiac and renal complications in Otsuka Long Evans Tokushima Fatty rats. Hypertension. 1997, 29: 728-735.CrossRefPubMed
12.
go back to reference Jia DM, Tabaru A, Nakamura H, Fukumitsu KI, Akiyama T, Otsuki M: Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes. Metabolism. 2000, 49: 1167-1175. 10.1053/meta.2000.8599.CrossRefPubMed Jia DM, Tabaru A, Nakamura H, Fukumitsu KI, Akiyama T, Otsuki M: Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes. Metabolism. 2000, 49: 1167-1175. 10.1053/meta.2000.8599.CrossRefPubMed
13.
go back to reference Abe T, Ohga Y, Tabayashi N, Kobayashi S, Sakata S, Misawa H, Tsuji T, Kohzuki H, Suga H, Taniguchi S, Takaki M: Leftventricular diastolic dysfunction in type 2 diabetes mellitus modelrats. Am J Phisiol. 2002, 282: H138-H148. Abe T, Ohga Y, Tabayashi N, Kobayashi S, Sakata S, Misawa H, Tsuji T, Kohzuki H, Suga H, Taniguchi S, Takaki M: Leftventricular diastolic dysfunction in type 2 diabetes mellitus modelrats. Am J Phisiol. 2002, 282: H138-H148.
14.
go back to reference Hayashi T, Sohmiya K, Ukimura A, Endoh S, Mori T, Shimomura H, Okabe M, Terasaki F, Kitaura Y: Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart. Heart. 2003, 89: 1236-1242. 10.1136/heart.89.10.1236.PubMedCentralCrossRefPubMed Hayashi T, Sohmiya K, Ukimura A, Endoh S, Mori T, Shimomura H, Okabe M, Terasaki F, Kitaura Y: Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart. Heart. 2003, 89: 1236-1242. 10.1136/heart.89.10.1236.PubMedCentralCrossRefPubMed
15.
go back to reference Saito F, Kawaguchi M, Izumida J, Asakura T, Maehara K, Maruyama Y: Alteration in haemodynamics and pathological changes inthe cardiovascular system during the development of Type 2 diabetes mellitus in OLETF rats. Diabetologia. 2003, 46: 1161-1169. 10.1007/s00125-003-1156-y.CrossRefPubMed Saito F, Kawaguchi M, Izumida J, Asakura T, Maehara K, Maruyama Y: Alteration in haemodynamics and pathological changes inthe cardiovascular system during the development of Type 2 diabetes mellitus in OLETF rats. Diabetologia. 2003, 46: 1161-1169. 10.1007/s00125-003-1156-y.CrossRefPubMed
16.
go back to reference El Banani H, Bernard M, Baets D, Cabanes E, Cozzone P, Lucien A, Feuvray D: Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazine. Comparison between low- and zero-flow ischaemia. Cardiovasc Res. 2000, 47: 688-696. 10.1016/S0008-6363(00)00136-X.CrossRefPubMed El Banani H, Bernard M, Baets D, Cabanes E, Cozzone P, Lucien A, Feuvray D: Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazine. Comparison between low- and zero-flow ischaemia. Cardiovasc Res. 2000, 47: 688-696. 10.1016/S0008-6363(00)00136-X.CrossRefPubMed
17.
go back to reference Anzawa R, Seki S, Horikoshi K, Onodera T, Taniguchi M, Mochizuki S: Ischaemic tolerance is attenuated in the spontaneously diabetic Otsuka Long-Evans Tokushima Fatty rats. Eur Heart J. 1999, 51-Suppl 20 Anzawa R, Seki S, Horikoshi K, Onodera T, Taniguchi M, Mochizuki S: Ischaemic tolerance is attenuated in the spontaneously diabetic Otsuka Long-Evans Tokushima Fatty rats. Eur Heart J. 1999, 51-Suppl 20
18.
go back to reference Cascio WE, Johnson TA, Gettes LS: Electrophysiologic changes in ischemic ventricular myocardium: I. Influence of ionic, metabolic and energic changes. J Cardiovasc Electrophysiol. 1995, 11: 1039-1062. 10.1111/j.1540-8167.1995.tb00381.x.CrossRef Cascio WE, Johnson TA, Gettes LS: Electrophysiologic changes in ischemic ventricular myocardium: I. Influence of ionic, metabolic and energic changes. J Cardiovasc Electrophysiol. 1995, 11: 1039-1062. 10.1111/j.1540-8167.1995.tb00381.x.CrossRef
19.
go back to reference Lu HR, Yang P, Remeysen P, Saels A, Dai DZ, De Clerck F: Ischemia/reperfusion induced arrhythmias in anaesthetized rats: a role of Na+ and Ca2+ influx. Eur J Pharmacol. 1999, 365: 233-239. 10.1016/S0014-2999(98)00878-4.CrossRefPubMed Lu HR, Yang P, Remeysen P, Saels A, Dai DZ, De Clerck F: Ischemia/reperfusion induced arrhythmias in anaesthetized rats: a role of Na+ and Ca2+ influx. Eur J Pharmacol. 1999, 365: 233-239. 10.1016/S0014-2999(98)00878-4.CrossRefPubMed
20.
go back to reference Pereira L, Matthes J, Schuster I, Valdivia HH, Herzig S, Richard S, Gomez AM: Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice. Diabetes. 2006, 55: 608-615. 10.2337/diabetes.55.03.06.db05-1284.CrossRefPubMed Pereira L, Matthes J, Schuster I, Valdivia HH, Herzig S, Richard S, Gomez AM: Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice. Diabetes. 2006, 55: 608-615. 10.2337/diabetes.55.03.06.db05-1284.CrossRefPubMed
21.
go back to reference Shimoni Y, Chuang M, Abel ED, Severson DL: Gender-dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice. J Physiol. 2004, 555: 345-354. 10.1113/jphysiol.2003.055590.PubMedCentralCrossRefPubMed Shimoni Y, Chuang M, Abel ED, Severson DL: Gender-dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice. J Physiol. 2004, 555: 345-354. 10.1113/jphysiol.2003.055590.PubMedCentralCrossRefPubMed
22.
go back to reference Zhu P, Lu L, Xu Y, Schwartz GG: Troglitazone improves recovery of left ventricular function after regional ischemia in pigs. Circulation. 2000, 101: 1165-1171.PubMedCentralCrossRefPubMed Zhu P, Lu L, Xu Y, Schwartz GG: Troglitazone improves recovery of left ventricular function after regional ischemia in pigs. Circulation. 2000, 101: 1165-1171.PubMedCentralCrossRefPubMed
23.
go back to reference Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J, PROactive investigators: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PRO active Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomized controlled trial. Lancet. 2005, 366: 1279-1289. 10.1016/S0140-6736(05)67528-9.CrossRefPubMed Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J, PROactive investigators: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PRO active Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomized controlled trial. Lancet. 2005, 366: 1279-1289. 10.1016/S0140-6736(05)67528-9.CrossRefPubMed
Metadata
Title
Exacerbation of acidosis during ischemia and reperfusion arrhythmia in hearts from type 2 Diabetic Otsuka Long-Evans Tokushima Fatty rats
Authors
Ryuko Anzawa
Shingo Seki
Kazuaki Horikoshi
Masayuki Taniguchi
Seibu Mochizuki
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2007
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-6-17

Other articles of this Issue 1/2007

Cardiovascular Diabetology 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.